Optiver Holding B.V. raised its stake in Tilray Brands, Inc. (NASDAQ:TLRY - Free Report) by 239.4% during the third quarter, according to its most recent disclosure with the SEC. The fund owned 224,049 shares of the company's stock after buying an additional 158,041 shares during the quarter. Optiver Holding B.V.'s holdings in Tilray Brands were worth $388,000 as of its most recent SEC filing.
Other institutional investors have also modified their holdings of the company. Dudley Capital Management LLC raised its stake in shares of Tilray Brands by 73.3% during the third quarter. Dudley Capital Management LLC now owns 26,000 shares of the company's stock valued at $45,000 after purchasing an additional 11,000 shares in the last quarter. Arizona State Retirement System raised its position in shares of Tilray Brands by 4.3% during the 3rd quarter. Arizona State Retirement System now owns 307,193 shares of the company's stock worth $531,000 after buying an additional 12,675 shares in the last quarter. Brighton Jones LLC raised its position in shares of Tilray Brands by 28.3% during the 3rd quarter. Brighton Jones LLC now owns 59,510 shares of the company's stock worth $103,000 after buying an additional 13,137 shares in the last quarter. Oppenheimer & Co. Inc. acquired a new stake in shares of Tilray Brands in the 3rd quarter worth approximately $25,000. Finally, Silverlake Wealth Management LLC bought a new position in shares of Tilray Brands in the third quarter valued at approximately $25,000. Institutional investors own 9.35% of the company's stock.
Analyst Ratings Changes
Several research analysts recently weighed in on the company. Canaccord Genuity Group initiated coverage on Tilray Brands in a research note on Tuesday, January 27th. They set a "hold" rating for the company. ATB Cormark Capital Markets raised shares of Tilray Brands from a "strong sell" rating to a "hold" rating in a research note on Wednesday, December 10th. Zacks Research upgraded Tilray Brands from a "strong sell" rating to a "hold" rating in a report on Wednesday, February 11th. Weiss Ratings reaffirmed a "sell (d-)" rating on shares of Tilray Brands in a research report on Wednesday, January 21st. Finally, Wall Street Zen upgraded Tilray Brands from a "sell" rating to a "hold" rating in a research report on Sunday, February 22nd. One equities research analyst has rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat, Tilray Brands presently has a consensus rating of "Hold" and a consensus target price of $13.33.
Check Out Our Latest Report on TLRY
Tilray Brands Trading Up 2.0%
Tilray Brands stock opened at $7.99 on Friday. Tilray Brands, Inc. has a 12 month low of $3.51 and a 12 month high of $23.20. The company has a quick ratio of 1.72, a current ratio of 2.81 and a debt-to-equity ratio of 0.19. The stock has a market cap of $930.91 million, a P/E ratio of -0.36 and a beta of 2.02. The company's fifty day simple moving average is $8.64 and its 200-day simple moving average is $11.09.
Tilray Brands (NASDAQ:TLRY - Get Free Report) last announced its quarterly earnings data on Thursday, January 8th. The company reported ($0.41) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.14) by ($0.27). Tilray Brands had a negative return on equity of 6.35% and a negative net margin of 251.69%.The firm had revenue of $217.51 million for the quarter, compared to analysts' expectations of $211.15 million. During the same quarter in the prior year, the business posted ($0.03) earnings per share. As a group, sell-side analysts forecast that Tilray Brands, Inc. will post -0.2 EPS for the current fiscal year.
Tilray Brands Profile
(
Free Report)
Tilray Brands, Inc is a global cannabis-lifestyle and consumer packaged goods company engaged in the cultivation, production, distribution and sale of cannabis and cannabinoid-based products. The company develops and markets a diverse portfolio of branded products spanning medical cannabis, adult-use recreational products and wellness offerings. Through state-of-the-art cultivation facilities, research and development efforts, and quality control systems, Tilray Brands aims to deliver consistent, scalable products for a range of patient and consumer needs.
Tilray's product lineup includes cannabis flower, pre-rolls, oils and tinctures, vapes, edibles and topicals, as well as hemp-derived cannabidiol (CBD) products.
Featured Stories
Want to see what other hedge funds are holding TLRY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tilray Brands, Inc. (NASDAQ:TLRY - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Tilray Brands, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tilray Brands wasn't on the list.
While Tilray Brands currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for April 2026. Learn which stocks have the most short interest and how to trade them. Click the link to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.